Eyetube Back Button
Interventional Glaucoma Case Series Image

Editorially independent content supported with advertising by Allergan (an AbbVie company), Glaukos, and New World Medical.

Minimizing the Medication Burden With Sustained Drug Delivery

I. Paul Singh, MD, Nathan M. Radcliffe, MD, Sarah Van Tassel, MD

I. Paul Singh, MD; Nathan Radcliffe, MD; and Sarah Van Tassel, MD, weigh in on a case that showcases the use of the Durysta bimatoprost implant (Allergan) in a patient who was intolerant of drops, with complaints of the associated side effects and costs. The experts discuss which patients are ideal candidates for this new treatment option and share strategies for effective patient counseling.

Other Videos

Thumbnail for bldqqi

Choosing an Approach Amid Postoperative Concerns

I. Paul Singh, MD, Nathan M. Radcliffe, MD, Sarah Van Tassel, MD

 Thumbnail for kbradw

A Tolerant Drop User With Visually Significant Cataracts

I. Paul Singh, MD, Nathan M. Radcliffe, MD, Sarah Van Tassel, MD

 Thumbnail for fazjndz

A Young Patient With Significant Glaucomatous Damage

I. Paul Singh, MD, Nathan M. Radcliffe, MD, Sarah Van Tassel, MD

 Thumbnail for guosro

Minimizing the Medication Burden With Sustained Drug Delivery

I. Paul Singh, MD, Nathan M. Radcliffe, MD, Sarah Van Tassel, MD

Editorially independent content supported with advertising by Allergan (an AbbVie company), Glaukos, and New World Medical.

Logos